Ibrutinib Plus Venetoclax in Relapsed/Refractory Chronic Lymphocytic Leukemia: The CLARITY Study. [electronic resource]
Producer: 20200610Description: 2722-2729 p. digitalISSN:- 1527-7755
- Adenine -- analogs & derivatives
- Adult
- Aged
- Aged, 80 and over
- Antineoplastic Combined Chemotherapy Protocols -- pharmacology
- Bridged Bicyclo Compounds, Heterocyclic -- pharmacology
- Female
- Humans
- Leukemia, Lymphocytic, Chronic, B-Cell -- drug therapy
- Male
- Middle Aged
- Piperidines
- Pyrazoles -- pharmacology
- Pyrimidines -- pharmacology
- Recurrence
- Sulfonamides -- pharmacology
No physical items for this record
Publication Type: Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.